dc.contributor.author | Hynnekleiv, Leif | |
dc.contributor.author | Thrane, Alexander Stanley | |
dc.contributor.author | Krohn, Jørgen | |
dc.date.accessioned | 2021-04-27T12:24:46Z | |
dc.date.available | 2021-04-27T12:24:46Z | |
dc.date.created | 2020-10-27T11:30:04Z | |
dc.date.issued | 2020 | |
dc.Published | BMJ Case Reports. 2020, 13:e235194 (10), 1-3. | |
dc.identifier.issn | 1757-790X | |
dc.identifier.uri | https://hdl.handle.net/11250/2739933 | |
dc.description.abstract | Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis and no known risk factors. To our knowledge, aqueous misdirection has not previously been associated with the use of tumour necrosis factor-alpha inhibitors. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BMJ | en_US |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/deed.no | * |
dc.title | Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2020 The Authors | en_US |
dc.source.articlenumber | e235194 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | 10.1136/bcr-2020-235194 | |
dc.identifier.cristin | 1842554 | |
dc.source.journal | BMJ Case Reports | en_US |
dc.source.40 | 13:e235194 | |
dc.source.14 | 10 | |
dc.identifier.citation | BMJ Case Reports. 2020;13:e235194 | en_US |
dc.source.volume | 13 | en_US |